The current PE ratio of PBH can't be determined, as the TTM EPS of -$1.6 is negative. The last recorded PE ratio for Prestige Consumer Healthcare was 14.87 in December 2022.
The average historical PE ratio of Prestige Consumer Healthcare for the last ten years is 20.5. Over the past ten years, PBH's PE ratio was at its highest in the Jun 2016 quarter at 42.95, when the stock price was $55.4 and the EPS was $1.29. The lowest value was in the Mar 2018 quarter, when it reached 5.27 with a price of $33.72 and an EPS of $6.4.
Maximum annual increase: 50.12% in 2017
Maximum annual decrease: -87.57% in 2018
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | 12.94 | -3.72% |
| 2021 | 13.44 | 2.99% |
| 2020 | 13.05 | N/A |
| 2019 | N/A | N/A |
| 2018 | 5.27 | -87.57% |
| 2017 | 42.41 | 50.12% |
| 2016 | 28.25 | -1.19% |
| 2015 | 28.59 | 47.9% |
| 2014 | 19.33 | -2.91% |
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 9.78 | $359.25B |
| CVS CVS HEALTH Corp | 9.79 | $70.18B |
| NVS Novartis AG | 13.13 | $198.47B |
| PG PROCTER & GAMBLE Co | 26.15 | $388.15B |
| ABT Abbott Laboratories | 32.79 | $184.23B |
| CLX Clorox Co | 71.25 | $17.17B |
| PFE Pfizer Inc | 73.18 | $157.04B |
| PBH Prestige Consumer Healthcare Inc | N/A | $3.48B |
The current price to earnings ratio of PBH can't be calculated, as its EPS of -$1.6 is negative.
The average PE ratio for PBH stock over the past 3 years is 14.4.
The average PE ratio for PBH stock over the past 5 years is 13.45.
In the last ten years, the Jun 2016 quarter recorded the highest quarterly PE ratio at 42.95.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.